BUSINESS WIRE - Allurion Technologies, a pioneering leader in the development of innovative, scalable and trusted weight loss experiences, today announced $34M in new funding through a securities financing and a growth capital term loan. [...] The company intends to use these proceeds to continue growing internationally and, subject to obtaining approval of the U.S. Food and Drug Administration (FDA), launching their revolutionary weight loss program in the United States.